H-Index
Rankings
United Kingdom Scientists H-Index Medical and Health Sciences / Medical Oncology Rankings in United Kingdom 2025
The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index"and Subject Rankings.
Breast cancer
angiogenesis
hypoxia
metabolism
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
209
86
0.411
Hemato-oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
133
72
0.541
Oncology
breast cancer
bone disease
trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
127
69
0.543
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
104
75
0.721
Prostate cancer
Voiding dissorder
imaging
trial design
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
97
65
0.670
oncology
radiation therapy
metastasis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
96
48
0.500
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
93
69
0.742
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
93
57
0.613
Lymphoma. Late treatment toxicity
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
92
51
0.554
HIV assocaited malignancy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
84
42
0.500
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
82
63
0.768
Oncology
DNA damage response
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
42
0.538
patient-reported outcomes
medical oncology
breast cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
76
56
0.737
Ovarian cancer
gene therapy
translational research
clinical trials
tumour microenvironment
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
72
53
0.736
Oncological Imaging
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
70
47
0.671
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
51
0.823
Medical Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
35
0.565
Clinical trials in breast cancer and gynaecological cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
61
30
0.492
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
53
0.964
Rectal and anal cancer
clinical trials
radiotherapy research
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
41
0.759
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
39
0.722
Molecular pathology
Colorectal cancer
Biomarkers
Bioinformatics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
38
0.776
Medical oncology
GU oncology
Tumour biology
Clinical trials
Drug Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
47
38
0.809
Oncology
Health Economics
Clinical Trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
37
0.860
Cancer Genetics and Genomics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
36
0.837
Adrian L Harris
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
209
86
0.411
Breast cancer
angiogenesis
hypoxia
metabolism
John Gribben
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
133
72
0.541
Robert Coleman
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
127
69
0.543
Oncology
breast cancer
bone disease
trials
dave cameron
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
104
75
0.721
Mark Emberton
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
97
65
0.670
Prostate cancer
Voiding dissorder
imaging
trial design
Ruth Muschel
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
96
48
0.500
oncology
radiation therapy
metastasis
JA Ledermann
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
93
69
0.742
Robert Huddart
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
93
57
0.613
John Radford
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
92
51
0.554
Lymphoma. Late treatment toxicity
Mark Bower
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
84
42
0.500
HIV assocaited malignancy
Nicholas James
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
82
63
0.768
Nicola Curtin
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
78
42
0.538
Oncology
DNA damage response
Galina Velikova
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
76
56
0.737
patient-reported outcomes
medical oncology
breast cancer
Iain Mcneish
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
72
53
0.736
Ovarian cancer
gene therapy
translational research
clinical trials
tumour microenvironment
Dow Mu Koh
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
70
47
0.671
Charlie Gourley
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
51
0.823
John Wagstaff
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
35
0.565
Timothy Perren
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
61
30
0.492
Clinical trials in breast cancer and gynaecological cancer
David James Pinato
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
53
0.964
David Sebag Montefiore
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
41
0.759
Rectal and anal cancer
clinical trials
radiotherapy research
Hardev Pandha
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
54
39
0.722
Enric Domingo
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
38
0.776
Molecular pathology
Colorectal cancer
Biomarkers
Bioinformatics
Syed A Hussain
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
47
38
0.809
Medical oncology
GU oncology
Tumour biology
Clinical trials
Drug Development
Peter S Hall
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
37
0.860
Oncology
Health Economics
Clinical Trials
Maya Ghoussaini
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
43
36
0.837
Cancer Genetics and Genomics